Jim Matthews
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jim Matthews has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Andrew John Anderson Holland
The Children's Hospital at Westmead Burns Unit, Kids Research Institute, Department of Paediatrics and Child Health, Sydney Medical School, The University of Sydney, New South Wales, Australia
2 shared publications - Arthur David Conigrave
School of Life and Environmental Sciences, Faculty of Science, The University of Sydney, Sydney, NSW, Australia
2 shared publications - Mark Stephen Rybchyn
Physiology, School of Medical Sciences, Sydney Medical School, Australia; Bosch Institute for Medical Research, Australia
2 shared publications - Rebecca Sara Mason
Bosch Institute, University of Sydney, Australia
2 shared publications - Adam Goldwater
Applied Horticultural Research, Biosciences Building, 1 Central Avenue, Eveleigh, Sydney, NSW 2015, Australia
1 shared publication - Alanna Wood
Department of Ophthalmology, Sydney Eye Hospital, Sydney, NSW, Australia; Department of Ophthalmology, Royal Darwin Hospital, Tiwi, NT, Australia
1 shared publication
Latest Publications
- Open Access
- 1 July 2023
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 17, 2171-2179
Prevalence of Glaucoma Following Paediatric Cataract Surgery in an Australian Tertiary Referral Centre
Purpose: Secondary glaucoma following childhood cataract surgery remains the most common complication in the paediatric population. This study aimed to determine the incidence, time to progression and risk factors associated with the development of secondary glaucoma following childhood cataract surgery in a paediatric population. Outcome measures were the detection of secondary glaucoma, postoperative time frame to development of glaucoma and risk factors in its development. Patients and Methods: A retrospective case series was conducted between 2003 and 2017 at a tertiary children’s hospital in Sydney. The patient population included those 16 years or less of age who underwent congenital cataract extraction, with or without an intraocular lens implantation and who had been followed up for a minimum of six months following surgery. Patients were excluded if they had cataract aetiology other than congenital idiopathic cataract. Multivariate Cox Regression analysis was used to determine relevant risk factors. Results: A total of 320 eyes in 216 patients were included in the study. Secondary glaucoma developed in 11.9% of eyes. In those that developed secondary glaucoma, the average time to onset from surgery was 3.2 years (median 2.75 years). The mean age of diagnosis of secondary glaucoma was 4.58 years (median 3.5 years, range 2.5 months to 13.23 years). Microcornea was the only adverse characteristic significantly associated with an increased risk of secondary glaucoma (HR 6.30, p 0.003). Conclusion: Despite modern surgical techniques, glaucoma remains a significant long-term sequela in children following cataract surgery.
- 1 July 2023
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 17, 2171-2179
Open AccessPrevalence of Glaucoma Following Paediatric Cataract Surgery in an Australian Tertiary Referral Centre
Purpose: Secondary glaucoma following childhood cataract surgery remains the most common complication in the paediatric population. This study aimed to determine the incidence, time to progression and risk factors associated with the development of secondary glaucoma following childhood cataract surgery in a paediatric population. Outcome measures were the detection of secondary glaucoma, postoperative time frame to development of glaucoma and risk factors in its development. Patients and Methods: A retrospective case series was conducted between 2003 and 2017 at a tertiary children’s hospital in Sydney. The patient population included those 16 years or less of age who underwent congenital cataract extraction, with or without an intraocular lens implantation and who had been followed up for a minimum of six months following surgery. Patients were excluded if they had cataract aetiology other than congenital idiopathic cataract. Multivariate Cox Regression analysis was used to determine relevant risk factors. Results: A total of 320 eyes in 216 patients were included in the study. Secondary glaucoma developed in 11.9% of eyes. In those that developed secondary glaucoma, the average time to onset from surgery was 3.2 years (median 2.75 years). The mean age of diagnosis of secondary glaucoma was 4.58 years (median 3.5 years, range 2.5 months to 13.23 years). Microcornea was the only adverse characteristic significantly associated with an increased risk of secondary glaucoma (HR 6.30, p 0.003). Conclusion: Despite modern surgical techniques, glaucoma remains a significant long-term sequela in children following cataract surgery.
- Open Access
- 3 March 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (5) , 4921
The CaSR Modulator NPS-2143 Reduced UV-Induced DNA Damage in Skh:hr1 Hairless Mice but Minimally Inhibited Skin Tumours
The calcium-sensing receptor (CaSR) is an important regulator of epidermal function. We previously reported that knockdown of the CaSR or treatment with its negative allosteric modulator, NPS-2143, significantly reduced UV-induced DNA damage, a key factor in skin cancer development. We subsequently wanted to test whether topical NPS-2143 could also reduce UV-DNA damage, immune suppression, or skin tumour development in mice. In this study, topical application of NPS-2143 (228 or 2280 pmol/cm2) to Skh:hr1 female mice reduced UV-induced cyclobutane pyrimidine dimers (CPD) (p < 0.05) and oxidative DNA damage (8-OHdG) (p < 0.05) to a similar extent as the known photoprotective agent 1,25(OH)2 vitamin D3 (calcitriol, 1,25D). Topical NPS-2143 failed to rescue UV-induced immunosuppression in a contact hypersensitivity study. In a chronic UV photocarcinogenesis protocol, topical NPS-2143 reduced squamous cell carcinomas for only up to 24 weeks (p < 0.02) but had no other effect on skin tumour development. In human keratinocytes, 1,25D, which protected mice from UV-induced skin tumours, significantly reduced UV-upregulated p-CREB expression (p < 0.01), a potential early anti-tumour marker, while NPS-2143 had no effect. This result, together with the failure to reduce UV-induced immunosuppression, may explain why the reduction in UV-DNA damage in mice with NPS-2143 was not sufficient to inhibit skin tumour formation.
- 3 March 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (5) , 4921
Open AccessThe CaSR Modulator NPS-2143 Reduced UV-Induced DNA Damage in Skh:hr1 Hairless Mice but Minimally Inhibited Skin Tumours
The calcium-sensing receptor (CaSR) is an important regulator of epidermal function. We previously reported that knockdown of the CaSR or treatment with its negative allosteric modulator, NPS-2143, significantly reduced UV-induced DNA damage, a key factor in skin cancer development. We subsequently wanted to test whether topical NPS-2143 could also reduce UV-DNA damage, immune suppression, or skin tumour development in mice. In this study, topical application of NPS-2143 (228 or 2280 pmol/cm2) to Skh:hr1 female mice reduced UV-induced cyclobutane pyrimidine dimers (CPD) (p < 0.05) and oxidative DNA damage (8-OHdG) (p < 0.05) to a similar extent as the known photoprotective agent 1,25(OH)2 vitamin D3 (calcitriol, 1,25D). Topical NPS-2143 failed to rescue UV-induced immunosuppression in a contact hypersensitivity study. In a chronic UV photocarcinogenesis protocol, topical NPS-2143 reduced squamous cell carcinomas for only up to 24 weeks (p < 0.02) but had no other effect on skin tumour development. In human keratinocytes, 1,25D, which protected mice from UV-induced skin tumours, significantly reduced UV-upregulated p-CREB expression (p < 0.01), a potential early anti-tumour marker, while NPS-2143 had no effect. This result, together with the failure to reduce UV-induced immunosuppression, may explain why the reduction in UV-DNA damage in mice with NPS-2143 was not sufficient to inhibit skin tumour formation.
- Open Access
- 29 March 2022
- Published by Wiley in Photochemistry and Photobiology
- Vol. 98 (5) , 1157-1166
UV‐induced DNA Damage in Skin is Reduced by CaSR Inhibition
The epidermis maintains a cellular calcium gradient that supports keratinocyte differentiation from its basal layers (low) to outer layers (high) leading to the development of the stratum corneum, which resists penetration of UV radiation. The calcium‐sensing receptor (CaSR) expressed in keratinocytes responds to the calcium gradient with signals that promote differentiation. In this study, we investigated whether the CaSR is involved more directly in protection from UV damage in studies of human keratinocytes in primary culture and in mouse skin studied in vivo. siRNA‐directed reductions in CaSR protein levels in human keratinocytes significantly reduced UV‐induced direct cyclobutane pyrimidine dimers (CPD) by ~80% and oxidative DNA damage (8‐OHdG) by ~65% compared with control transfected cells. Similarly, in untransfected cells, the CaSR negative modulator, NPS‐2143 (500 nm), reduced UV‐induced CPD and 8‐OHdG by ~70%. NPS‐2143 also enhanced DNA repair and reduced reactive oxygen species (ROS) by ~35% in UV‐exposed keratinocytes, consistent with reduced DNA damage after UV exposure. Topical application of NPS‐2143 also protected hairless Skh:hr1 mice from UV‐induced CPD, oxidative DNA damage and inflammation, similar to the reductions observed in response to the well‐known photoprotection agent 1,25(OH)2D3 (calcitriol). Thus, negative modulators of the CaSR offer a new approach to reducing UV‐induced skin damage.
- 29 March 2022
- Published by Wiley in Photochemistry and Photobiology
- Vol. 98 (5) , 1157-1166
Open AccessUV‐induced DNA Damage in Skin is Reduced by CaSR Inhibition
The epidermis maintains a cellular calcium gradient that supports keratinocyte differentiation from its basal layers (low) to outer layers (high) leading to the development of the stratum corneum, which resists penetration of UV radiation. The calcium‐sensing receptor (CaSR) expressed in keratinocytes responds to the calcium gradient with signals that promote differentiation. In this study, we investigated whether the CaSR is involved more directly in protection from UV damage in studies of human keratinocytes in primary culture and in mouse skin studied in vivo. siRNA‐directed reductions in CaSR protein levels in human keratinocytes significantly reduced UV‐induced direct cyclobutane pyrimidine dimers (CPD) by ~80% and oxidative DNA damage (8‐OHdG) by ~65% compared with control transfected cells. Similarly, in untransfected cells, the CaSR negative modulator, NPS‐2143 (500 nm), reduced UV‐induced CPD and 8‐OHdG by ~70%. NPS‐2143 also enhanced DNA repair and reduced reactive oxygen species (ROS) by ~35% in UV‐exposed keratinocytes, consistent with reduced DNA damage after UV exposure. Topical application of NPS‐2143 also protected hairless Skh:hr1 mice from UV‐induced CPD, oxidative DNA damage and inflammation, similar to the reductions observed in response to the well‐known photoprotection agent 1,25(OH)2D3 (calcitriol). Thus, negative modulators of the CaSR offer a new approach to reducing UV‐induced skin damage.
- Open Access
- 1 May 2021
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 8 (3)
Interferon-β Is Less Effective Than Other Drugs in Controlling the Rate of Retinal Ganglion Cell Loss in MS
Objective To investigate the association between disease-modifying therapies (DMTs) and the rate of progressive retinal ganglion cell (RGC) and nerve fiber loss in MS. Methods One hundred five relapsing-remitting patients with MS were followed annually for a median of 4.0 years using optical coherence tomography. Twenty-five healthy subjects were also included as normal controls. The rates of global peripapillary retinal nerve fiber layer (pRNFL), temporal RNFL (tRNFL), and ganglion cell inner plexiform layer (GCIPL) thinning were analyzed according to DMT type using a linear mixed-effects model. Optic radiation lesion volume was measured on brain MRI and included as a covariate to minimize the effects of retrograde transsynaptic degeneration. Results The annual rates of RNFL and GCIPL thinning were higher in patients treated with “platform” therapies (interferon-β and glatiramer acetate) compared with DMTs of higher clinical efficacy (including fingolimod, dimethyl fumarate, natalizumab, alemtuzumab, rituximab, and ocrelizumab) (difference = −0.22 μm/y, p = 0.02 for pRNFL; difference = −0.34 μm/y, p = 0.009 for tRNFL; and difference = −0.16 μm/y, p = 0.005 for GCIPL). Based on an analysis of individual treatments (interferon-β, glatiramer acetate, fingolimod, and natalizumab), interferon-β was associated with inferior RGC preservation, relative to the other drugs. No effect difference was found between glatiramer acetate, fingolimod, and natalizumab. Conclusions Progressive loss of RGCs in patients with MS is more pronounced in patients treated with interferon-β than other DMTs. This finding may have implications for DMT selection in MS. Classification of Evidence This study provides Class IV evidence that for patients with MS, treatment with interferon-β compared with other DMTs leads to a more pronounced rate of retinal ganglion cell loss.
- 1 May 2021
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 8 (3)
Open AccessInterferon-β Is Less Effective Than Other Drugs in Controlling the Rate of Retinal Ganglion Cell Loss in MS
Objective To investigate the association between disease-modifying therapies (DMTs) and the rate of progressive retinal ganglion cell (RGC) and nerve fiber loss in MS. Methods One hundred five relapsing-remitting patients with MS were followed annually for a median of 4.0 years using optical coherence tomography. Twenty-five healthy subjects were also included as normal controls. The rates of global peripapillary retinal nerve fiber layer (pRNFL), temporal RNFL (tRNFL), and ganglion cell inner plexiform layer (GCIPL) thinning were analyzed according to DMT type using a linear mixed-effects model. Optic radiation lesion volume was measured on brain MRI and included as a covariate to minimize the effects of retrograde transsynaptic degeneration. Results The annual rates of RNFL and GCIPL thinning were higher in patients treated with “platform” therapies (interferon-β and glatiramer acetate) compared with DMTs of higher clinical efficacy (including fingolimod, dimethyl fumarate, natalizumab, alemtuzumab, rituximab, and ocrelizumab) (difference = −0.22 μm/y, p = 0.02 for pRNFL; difference = −0.34 μm/y, p = 0.009 for tRNFL; and difference = −0.16 μm/y, p = 0.005 for GCIPL). Based on an analysis of individual treatments (interferon-β, glatiramer acetate, fingolimod, and natalizumab), interferon-β was associated with inferior RGC preservation, relative to the other drugs. No effect difference was found between glatiramer acetate, fingolimod, and natalizumab. Conclusions Progressive loss of RGCs in patients with MS is more pronounced in patients treated with interferon-β than other DMTs. This finding may have implications for DMT selection in MS. Classification of Evidence This study provides Class IV evidence that for patients with MS, treatment with interferon-β compared with other DMTs leads to a more pronounced rate of retinal ganglion cell loss.
- Open Access
- 28 December 2020
- Published by MDPI AG in Agriculture
- Vol. 11 (1) , 14
Persistence of Human Pathogens in Manure-Amended Australian Soils Used for Production of Leafy Vegetables
Incorporation of manures into soil can add nutrients, improve soil structure and enhance biodiversity, thereby improving the sustainability of vegetable production systems. Unfortunately, manures can also potentially contain human enteric pathogens. To reduce the risk of contamination, Australian guidelines recommend a withholding period of 90 days between manure application and harvest for high-risk products such as leafy salad greens. Our study examined the appropriateness of these guidelines under conditions replicating those on a commercial vegetable farm. Cow manure and poultry litter with/without addition of non-pathogenic strains of Escherichia coli (E. coli), Listeriainnocua and Salmonella sv. sofia were added to sandy and clay loam soils typical of those used to grow vegetables. Bacterial populations were monitored in the soil and on crops of cos lettuce during spring (A), summer (B) and autumn (C) trials, with testing conducted by a commercial laboratory. Significant declines in E. coli occurred within 6 to 16 days in all trials. Modelling indicated that E. coli populations would be at or close to the limit of detection within 50 days for all of the combinations tested. A 2–3 log die-off of Salmonella spp. occurred within three weeks. However, occasional detections continued throughout trial A. As a result, the probability of detection after 50 days fell from 1.0 to 0.1 and 0.02 in trials B and C, respectively, but remained at 0.44 in trial A. Listeria spp. was the most persistent in soil but was not detected on lettuce at commercial maturity. While this study was limited in scope, the results suggest that a 90 day withholding period between application of manure and harvest significantly reduces risk from enteric pathogens under Australian field conditions.
- 28 December 2020
- Published by MDPI AG in Agriculture
- Vol. 11 (1) , 14
Open AccessPersistence of Human Pathogens in Manure-Amended Australian Soils Used for Production of Leafy Vegetables
Incorporation of manures into soil can add nutrients, improve soil structure and enhance biodiversity, thereby improving the sustainability of vegetable production systems. Unfortunately, manures can also potentially contain human enteric pathogens. To reduce the risk of contamination, Australian guidelines recommend a withholding period of 90 days between manure application and harvest for high-risk products such as leafy salad greens. Our study examined the appropriateness of these guidelines under conditions replicating those on a commercial vegetable farm. Cow manure and poultry litter with/without addition of non-pathogenic strains of Escherichia coli (E. coli), Listeriainnocua and Salmonella sv. sofia were added to sandy and clay loam soils typical of those used to grow vegetables. Bacterial populations were monitored in the soil and on crops of cos lettuce during spring (A), summer (B) and autumn (C) trials, with testing conducted by a commercial laboratory. Significant declines in E. coli occurred within 6 to 16 days in all trials. Modelling indicated that E. coli populations would be at or close to the limit of detection within 50 days for all of the combinations tested. A 2–3 log die-off of Salmonella spp. occurred within three weeks. However, occasional detections continued throughout trial A. As a result, the probability of detection after 50 days fell from 1.0 to 0.1 and 0.02 in trials B and C, respectively, but remained at 0.44 in trial A. Listeria spp. was the most persistent in soil but was not detected on lettuce at commercial maturity. While this study was limited in scope, the results suggest that a 90 day withholding period between application of manure and harvest significantly reduces risk from enteric pathogens under Australian field conditions.